A detailed history of Mercer Global Advisors Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Mercer Global Advisors Inc holds 350,500 shares of AMRN stock, worth $4.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
350,500
Previous 352,000 0.43%
Holding current value
$4.15 Million
Previous $168,000 1769.05%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$0.4 - $8.96 $600 - $13,440
-1,500 Reduced 0.43%
350,500 $3.14 Million
Q4 2024

Feb 14, 2025

BUY
$0.44 - $0.63 $154,880 - $221,760
352,000 New
352,000 $168,000
Q3 2021

Nov 10, 2021

SELL
$3.94 - $5.84 $52,275 - $77,485
-13,268 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$4.26 - $6.5 $56,521 - $86,242
13,268 New
13,268 $58,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $4.78B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.